A collection of 344 innovative screening compounds, based on a series of carefully selected new original scaffolds. All molecules have been designed to ensure optimal diversity, and are suitable for diverse chemical modification yielding analogs with promising IP positions. The library combines potential high therapeutic score with favorable drug-like and ADME-Tox properties.
Two different presentations:
|pre-dissolved in DMSO ready for screening at precise 10 mM concentration and tailored volumes (100 µL to 1 mL) in 96 or 384 well plates, and customizable (volumes, plating).|
|as dry powder in vials starting at 10 mg, with cherry-picking possibility.|